ALB and liver cancer: A notable inverse linear relationship was reported between serum ALB level ([ALB]serum) and liver cancer risk7, and a low (<3.5 g/dl) [ALB]serum predicts worse overall survival than a high (≥3.5 g/dl) [ALB]serum in patients with HCC3.